{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:36:45Z","timestamp":1788687405068,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0057-7","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T22:04:21Z","timestamp":1435874661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans"],"prefix":"10.1186","volume":"14","author":[{"given":"Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany A.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Yarborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chien","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley M.","family":"Argraves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1902\/jop.2008.080183","volume":"79","author":"D Graves","year":"2008","unstructured":"Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008;79:1585\u201391.","journal-title":"J Periodontol"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1194\/jlr.M031427","volume":"54","author":"H Yu","year":"2013","unstructured":"Yu H, Valerio M, Bielawski J. Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans. J Lipid Res. 2013;54:189\u2013201.","journal-title":"J Lipid Res"},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cytogfr.2010.09.004","volume":"22","author":"P Xia","year":"2011","unstructured":"Xia P, Wadham C. Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. Cytokine Growth Factor Rev. 2011;22:45\u201353.","journal-title":"Cytokine Growth Factor Rev"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nri2974","volume":"11","author":"S Spiegel","year":"2011","unstructured":"Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011;11:403\u201315.","journal-title":"Nat Rev Immunol"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.biochi.2010.02.008","volume":"92","author":"AJ Snider","year":"2010","unstructured":"Snider AJ, Orr Gandy KA, Obeid LM. Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation. Biochimie. 2010;92:707\u201315.","journal-title":"Biochimie"},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/pr.107.07113","volume":"60","author":"K Takabe","year":"2008","unstructured":"Takabe K, Paugh SW, Milstien S, Spiegel S. \u201cInside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev. 2008;60:181\u201395.","journal-title":"Pharmacol Rev"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature07713","volume":"458","author":"M Ishii","year":"2009","unstructured":"Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009;458:524\u20138.","journal-title":"Nature"},{"key":"57_CR8","first-page":"223","volume":"2013","author":"M Ishii","year":"1831","unstructured":"Ishii M, Kikuta J. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim Biophys Acta. 1831;2013:223\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012;22:50\u201360.","journal-title":"Trends Cell Biol"},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel GT, Maceyka M, Milstien S, Spiegel S. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov. 2013;12:688\u2013702.","journal-title":"Nat Rev Drug Discov"},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0022034510389178","volume":"90","author":"JJ Aarthi","year":"2011","unstructured":"Aarthi JJ, Darendeliler MA, Pushparaj PN. Dissecting the role of the S1P\/S1PR axis in health and disease. J Dent Res. 2011;90:841\u201354.","journal-title":"J Dent Res"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4155\/fmc.12.28","volume":"4","author":"WQ Lai","year":"2012","unstructured":"Lai WQ, Chia FL, Leung BP. Sphingosine kinase and sphingosine-1-phosphate receptors: novel therapeutic targets of rheumatoid arthritis? Future Med Chem. 2012;4:727\u201333.","journal-title":"Future Med Chem"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","volume":"25","author":"J Ryu","year":"2006","unstructured":"Ryu J, Kim HJ, Chang EJ, Huang H, Banno Y, Kim HH. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006;25:5840\u201351.","journal-title":"EMBO J"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"E1421","DOI":"10.1210\/jc.2012-1044","volume":"97","author":"SH Lee","year":"2012","unstructured":"Lee SH, Lee SY, Lee YS, Kim BJ, Lim KH, Cho EH, et al. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. J Clin Endocrinol Metab. 2012;97:E1421\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.7164\/antibiotics.47.208","volume":"47","author":"T Fujita","year":"1994","unstructured":"Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, et al. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J Antibiot (Tokyo). 1994;47:208\u201315.","journal-title":"J Antibiot (Tokyo)"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","volume":"18","author":"MH Graler","year":"2004","unstructured":"Graler MH, Goetzl EJ. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 2004;18:551\u20133.","journal-title":"FASEB J"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/eji.200425556","volume":"35","author":"H Muller","year":"2005","unstructured":"Muller H, Hofer S, Kaneider N, Neuwirt H, Mosheimer B, Mayer G, et al. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol. 2005;35:533\u201345.","journal-title":"Eur J Immunol"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/1352458511411061","volume":"17","author":"X Montalban","year":"2011","unstructured":"Montalban X, Comi G, O\u2019Connor P, Gold S, de Vera A, Eckert B, et al. Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study. Mult Scler. 2011;17:1341\u201350.","journal-title":"Mult Scler"},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1093\/ndt\/gfr503","volume":"26","author":"AJ Hoitsma","year":"2011","unstructured":"Hoitsma AJ, Woodle ES, Abramowicz D, Proot P, Vanrenterghem Y. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study. Nephrol Dial Transplant. 2011;26:3802\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00296-010-1634-8","volume":"31","author":"J Kikuta","year":"2011","unstructured":"Kikuta J, Iwai K, Saeki Y, Ishii M. S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. Rheumatol Int. 2011;31:967\u20139.","journal-title":"Rheumatol Int"},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.abb.2008.03.037","volume":"473","author":"HK Vaananen","year":"2008","unstructured":"Vaananen HK, Laitala-Leinonen T. Osteoclast lineage and function. Arch Biochem Biophys. 2008;473:132\u20138.","journal-title":"Arch Biochem Biophys"},{"key":"57_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2741\/4242","volume":"19","author":"W Feng","year":"2014","unstructured":"Feng W, Xia W, Ye Q, Wu W. Osteoclastogenesis and osteoimmunology. Front Biosci (Landmark Ed). 2014;19:758\u201367.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.biocel.2009.12.018","volume":"42","author":"Q Zhao","year":"2010","unstructured":"Zhao Q, Wang X, Liu Y, He A, Jia R. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol. 2010;42:576\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4049\/jimmunol.1002483","volume":"186","author":"K Nemeth","year":"2011","unstructured":"Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R, Hofbauer LC, et al. The role of osteoclast-associated receptor in osteoimmunology. J Immunol. 2011;186:13\u20138.","journal-title":"J Immunol"},{"key":"57_CR25","first-page":"1541","volume":"63","author":"K Matsuo","year":"2005","unstructured":"Matsuo K, Irie N. Transcription factors in osteoclast differentiation. Nihon Rinsho. 2005;63:1541\u20136.","journal-title":"Nihon Rinsho"},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.4155\/fmc.12.25","volume":"4","author":"K Chiba","year":"2012","unstructured":"Chiba K, Adachi K. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis. Future Med Chem. 2012;4:771\u201381.","journal-title":"Future Med Chem"},{"key":"57_CR27","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289:1504\u20138.","journal-title":"Science"},{"key":"57_CR28","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00018-012-1238-4","volume":"70","author":"T Oikawa","year":"2013","unstructured":"Oikawa T, Kuroda Y, Matsuo K. Regulation of osteoclasts by membrane-derived lipid mediators. Cell Mol Life Sci. 2013;70:3341\u201353.","journal-title":"Cell Mol Life Sci"},{"key":"57_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004;427:355\u201360.","journal-title":"Nature"},{"key":"57_CR30","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","volume":"160","author":"K Chiba","year":"1998","unstructured":"Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol. 1998;160:5037\u201344.","journal-title":"J Immunol"},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-9-1","volume":"9","author":"A Ngkelo","year":"2012","unstructured":"Ngkelo A, Meja K, Yeadon M, Adcock I, Kirkham PA. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gialpha dependent PI-3kinase signalling. J Inflamm (Lond). 2012;9:1.","journal-title":"J Inflamm (Lond)"},{"key":"57_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2015.01.160","volume":"458","author":"D Shi-Lin","year":"2015","unstructured":"Shi-Lin D, Yuan X, Zhan S, Luo-Jia T, Chao-Yang T. Trametinib, a novel MEK kinase inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor (TNF)-alpha production and endotoxin shock. Biochem Biophys Res Commun. 2015;458:667\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"57_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","volume":"256","author":"H Noda","year":"2013","unstructured":"Noda H, Takeuchi H, Mizuno T, Suzumura A. Fingolimod phosphate promotes the neuroprotective effects of microglia. J Neuroimmunol. 2013;256:13\u20138.","journal-title":"J Neuroimmunol"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"21453","DOI":"10.1074\/jbc.C200176200","volume":"277","author":"V Brinkmann","year":"2002","unstructured":"Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem. 2002;277:21453\u20137. Epub 22002 Apr 21419.","journal-title":"J Biol Chem"},{"key":"57_CR35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/science.1070238","volume":"296","author":"S Mandala","year":"2002","unstructured":"Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002;296:346\u20139.","journal-title":"Science"},{"key":"57_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. J Bone Metab. 2014;21:233\u201341.","journal-title":"J Bone Metab"},{"key":"57_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/gt.2010.139","volume":"18","author":"H Yu","year":"2011","unstructured":"Yu H, Li Q, Herbert B, Zinna R, Martin K, Junior CR, et al. Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss. Gene Ther. 2011;18:344\u201353.","journal-title":"Gene Ther"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-015-0057-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0057-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T23:35:09Z","timestamp":1691796909000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-015-0057-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0057-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]},"assertion":[{"value":"2 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"66"}}